Skip to main content
Clinical Trials/NL-OMON21478
NL-OMON21478
Recruiting
Not Applicable

Sleep positional therapy for the treatment of nocturnal gastroesophageal reflux

Amsterdam UMC0 sites45 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Amsterdam UMC
Enrollment
45
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Amsterdam UMC

Eligibility Criteria

Inclusion Criteria

  • Written informed consent.
  • \-Both male and female patients will be included.
  • \-Age above 18 years.
  • \-Symptoms of heartburn and/or acid regurgitation at least 2 times a week during the night.
  • \-A total reflux symptom score \=8 (measured through the GERDQ questionnaire score).
  • \-Minimal of 1\.5% esophageal acid exposure during the night.

Exclusion Criteria

  • \-Surgery of the GI tract other than appendectomy or cholecystectomy.
  • \-Use of any medication with a potential effect on gastrointestinal motility, secretion or sensitivity that cannot be stopped for the duration of the study (e.g. H2\-blockers, antidepressants, prokinetics).
  • \-History of gastrointestinal cancer.
  • \-Known diabetes.
  • \-Regular use of sleep medication (benzodiazepines) that cannot be stopped.
  • \-Severe and clinically unstable concomitant disease (e.g. liver, cardiovascular or lung disease, neurological or psychiatric disorders, cancer or AIDS and other endocrine disorders).
  • \-Pregnant or lactating women. Women will be asked if they are pregnant.
  • \-Patients that sleep \>75% of Total Sleep Time (TST) on their left side
  • \-Patients that sleep \<10% of TST on their right side

Outcomes

Primary Outcomes

Not specified

Similar Trials